Status:
UNKNOWN
Risk Factors Analysis for Acute Myocardial Infarction Patients
Lead Sponsor:
Genglong Liu
Conditions:
AMI - Acute Mesenteric Ischemia
Extracorporeal Membrane Oxygenation Complication
Eligibility:
All Genders
18+ years
Brief Summary
ECMO has been used to save the lives of many critically ill patients with cardiorespiratory dysfunction as important rescue therapy. Though the proportion of ECMO applied to this population has been i...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Alzheimer's Disease Age more than 18
Exclusion
- Life expectancy \<1 year Prolonged cardiac arrest before VA-ECMO therapy (\>60 min) Iatrogenic myocardial infarction secondary to a percutaneous coronary intervention VA-ECMO implanted in another center before admission
Key Trial Info
Start Date :
January 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 12 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05390658
Start Date
January 11 2020
End Date
January 12 2023
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Genglong Liu
Guangzhou, State..., China, 510080